DXC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DXC Technology Co is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows mixed signals with no strong positive catalysts, a bearish technical trend, and limited upside potential based on analyst ratings and price targets. While the company's net income and EPS have improved significantly YoY, revenue and gross margin have declined, and the stock lacks clear momentum or strong institutional support.
The MACD is positive and expanding, indicating some bullish momentum, but the RSI is neutral at 62.158, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 13.288), suggesting limited immediate upside potential. The stock's historical trend indicates a 70% chance of minor gains in the next day but significant declines over the next week and month.
The company's net income increased by 87.72% YoY, and EPS grew by 96.77% YoY in Q3 2026, showing profitability improvement. AI and go-to-market efforts are highlighted as areas of progress by management.
Revenue declined by 0.96% YoY, and gross margin dropped by 1.72% YoY. Analysts have lowered price targets, with one maintaining an Underperform rating. The Q4 revenue guidance was disappointing, and the stock has no significant trading trends from hedge funds or insiders. No recent news or congress trading data is available to drive positive sentiment.
In Q3 2026, revenue dropped to $3.19 billion (-0.96% YoY), net income increased to $107 million (+87.72% YoY), EPS rose to 0.61 (+96.77% YoY), and gross margin declined to 14.9% (-1.72% YoY). While profitability improved, revenue and margins are under pressure.
Analysts have mixed views. BMO Capital raised the price target to $17 from $15 but maintained a Market Perform rating, citing progress in AI efforts but concerns about revenue stability. Wolfe Research lowered the price target to $13 from $14 and maintained an Underperform rating, citing softer-than-expected Q4 guidance.
